中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2020 Vol. 36, No. 9

Display Method:
Editorial
Accurate prediction of clinical endpoints of liver cirrhosis
Zhou JiaLing, You Hong
2020, 36(9): 1921-1922. DOI: 10.3969/j.issn.1001-5256.2020.09.001
Abstract(1374) PDF (152KB)(308)
Abstract:
Although etiological treatment has reduced the incidence and mortality rates of liver cirrhosis complications,some patients may still experience disease progression. It is of great importance for further reducing mortality rate to accurately predict the clinical endpoints of liver cirrhosis and stre...
Discussions by experts
Methodology of establishing predictive models for clinical endpoints in patients with chronic hepatitis B
Wu ShanShan, Kong YuanYuan
2020, 36(9): 1923-1927. DOI: 10.3969/j.issn.1001-5256.2020.09.002
Abstract(1350) PDF (357KB)(202)
Abstract:
It is of great clinical significance to achieve accurate prediction of clinical endpoints in patients with chronic hepatitis B( CHB),identify the patients at a high risk of decompensated cirrhosis or hepatocellular carcinoma,and thus strengthen intervention to reduce the corresponding mortality rate...
Histological prediction of clinical endpoints of liver cirrhosis
Zhang MengYang, Sun YaMeng
2020, 36(9): 1928-1930. DOI: 10.3969/j.issn.1001-5256.2020.09.003
Abstract(1336) PDF (181KB)(123)
Abstract:
Patients with liver cirrhosis have different clinical manifestations and prognoses,and it is necessary to accurately predict the clinical endpoints of liver cirrhosis. Liver pathology can directly display the change in liver structure and thus plays an important role in predicting clinical endpoints...
Value of hepatic venous pressure gradient in predicting clinical end events in liver cirrhosis
He FuLiang, Ou XiaoJuan, Wang Min, Zhang GuanHua, Wang Yu
2020, 36(9): 1931-1935. DOI: 10.3969/j.issn.1001-5256.2020.09.004
Abstract(1484) PDF (493KB)(147)
Abstract:
Liver cirrhosis is the end stage of liver disease,and decompensated liver cirrhosis has the significant feature of portal hypertension. At present,hepatic venous pressure gradient( HVPG) remains the “gold standard”for evaluating portal hypertension and thus has great significance in clinical practic...
Value of imaging technology in predicting the clinical end events of liver cirrhosis
Wang Liang, Li YongFang, Zhang LingYi
2020, 36(9): 1936-1940. DOI: 10.3969/j.issn.1001-5256.2020.09.005
Abstract(1472) PDF (249KB)(155)
Abstract:
The clinical end events of liver cirrhosis have great adverse influence on patients,among which esophageal and gastric varices,portal vein thrombosis,and primary liver cancer might lead to low quality of life and even death. The rapid development of imaging technology provides an important reference...
Value of noninvasive indicators in predicting clinical outcome events of liver cirrhosis
Xu MingYi, Xu ZiXin
2020, 36(9): 1941-1946. DOI: 10.3969/j.issn.1001-5256.2020.09.006
Abstract(1397) PDF (297KB)(168)
Abstract:
At present,more and more studies have been conducted on noninvasive diagnostic indicators for liver cirrhosis,but no consensus has been reached on the association of noninvasive diagnostic indicators with clinical outcome events and their predictive value. This article summarizes the value of noninv...
Guidelines
Expert consensus on the MDT model of pancreatic cancer in China( 2020 version)
Chinese Society for Clinical Oncologists, Expert Committee on Pancreatic Diseases, China International Exchange and Promotive Association for Medical and Health Care, Expert Committee on Abdominal Neoplasms, China Medicine Education Association
2020, 36(9): 1947-1951. DOI: 10.3969/j.issn.1001-5256.2020.09.007
Abstract(1072) PDF (257KB)(396)
Abstract:

The current situation of pancreatic cancer is that the etiology is not clear and prevention is impossible. The sensitivity and specificity of the auxiliary detection methods are low,and early diagnosis is a worldwide problem. The efficacy of existing treatment methods is not satisfactory,and it is d...

An excerpt of Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations
Feng RuiRui, Ji FanPu, Qi XingShun
2020, 36(9): 1952-1954. DOI: 10.3969/j.issn.1001-5256.2020.09.008
Abstract:
Original articles_Liver fibrosis and liver cirrhosis
Value of fibrosis-4,aspartate aminotransferase-to-platelet ratio index,and globulin-platelet index in the diagnosis of significant liver fibrosis in autoimmune hepatitis
Chen Wei, Hong RuTao, Liu XiaoChang, Hu HuaQing
2020, 36(9): 1955-1959. DOI: 10.3969/j.issn.1001-5256.2020.09.009
Abstract(1693) PDF (352KB)(145)
Abstract:
Objective To investigate the value of fibrosis-4( FIB-4),aspartate aminotransferase-to-platelet ratio index( APRI),and globulin-platelet index( GPI) in the diagnosis of significant liver fibrosis in autoimmune hepatitis( AIH). Methods A total of 47 AIH patients who were hospitalized and underwent li...
Development and prognosis of acute-on-chronic liver failure in patients with acute deterioration of hepatitis B virus-related liver cirrhosis
Li Chen, Tan JunYuan, Xu Xiang
2020, 36(9): 1960-1965. DOI: 10.3969/j.issn.1001-5256.2020.09.010
Abstract(1480) PDF (408KB)(114)
Abstract:

Objective To investigate the 28-day incidence rate of acute-on-chronic liver failure( ACLF) and the 90-day prognosis of patients with acute deterioration( AD) of hepatitis B virus( HBV)-related liver cirrhosis( LC). Methods A total of 670 patients with AD of HBV-related LC who were admitted to The F...

Measurement and clinical significance of peripheral blood vascular endothelial growth factor in patients with liver cirrhosis and portal vein thrombosis
Yao YunHai, Luo Yan, Zhu JingLe, Gan JianHe, Zhao WeiFeng
2020, 36(9): 1966-1969. DOI: 10.3969/j.issn.1001-5256.2020.09.011
Abstract(1264) PDF (399KB)(120)
Abstract:
Objective To investigate the level of vascular endothelial growth factor( VEGF) in the peripheral blood of patients with liver cirrhosis and portal vein thrombosis( PVT) and its clinical significance in the diagnosis of liver cirrhosis with PVT. Methods A total of 60 patients with liver cirrhosis an...
Effect of intraoperative Viatorr stent implantation for shunting of blood flow in the left or right branch of the portal vein and its effect on clinical outcome in patients with cirrhotic portal hypertension undergoing transjugular intrahepatic portosystemic shunt
Yao Xin, Zhou Hao, Tang ShanHong, Huang Shan, Chen XueLing, Qin JianPing
2020, 36(9): 1970-1974. DOI: 10.3969/j.issn.1001-5256.2020.09.012
Abstract(1444) PDF (572KB)(130)
Abstract:

Objective To investigate the effect of intraoperative Viatorr stent implantation for shunting of blood flow in the left or right branch of the portal vein on the clinical outcome of patients with cirrhotic portal hypertension undergoing transjugular intrahepatic portosystemic shunt( TIPS). Methods A...

Original articles_Liver neoplasms
Effect of entecavir antiviral therapy alone or combined with interferon on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
Sun Jing, Zhu Lin, Chi Xin, Wang YiXuan, Xing HuiChun
2020, 36(9): 1975-1979. DOI: 10.3969/j.issn.1001-5256.2020.09.013
Abstract(1502) PDF (459KB)(143)
Abstract:

Objective To investigate the effect of entecavir( ETV) alone or combined with interferon( IFN) on the risk of hepatocellular carcinoma( HCC) in patients with chronic hepatitis B( CHB). Methods A retrospective analysis was performed for 409 patients with CHB who were admitted to Beijing Ditan Hospita...

Value of ABCR scoring system in assessing the prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization
Yang Jun, Yin Yu, Ni CaiFang, Zhu XiaoLi, Li Zhi, Zhang Shen, Huang Peng, Wang WanSheng
2020, 36(9): 1980-1984. DOI: 10.3969/j.issn.1001-5256.2020.09.014
Abstract(1312) PDF (423KB)(123)
Abstract:

Objective To investigate the value of ABCR clinical scoring system in guiding repeated transcatheter arterial chemoembolization( TACE) therapy for patients with hepatocellular carcinoma( HCC) and the treatment strategies for patients with an ABCR score of 1-3.Methods The patients with HCC who underw...

Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis
Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing
2020, 36(9): 1985-1989. DOI: 10.3969/j.issn.1001-5256.2020.09.015
Abstract(1362) PDF (382KB)(116)
Abstract:

Objective To investigate the risk factors for tumor recurrence and death after liver transplantation in patients with hepatocellular carcinoma( HCC) and their survival. Methods The patients with HCC who underwent liver transplantation in The Fifth Medical Center of Chinese PLA General Hospital from ...

Value of abnormal prothrombin in evaluating the short-term efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
Cha JunHao, Guo JinHe
2020, 36(9): 1990-1993. DOI: 10.3969/j.issn.1001-5256.2020.09.016
Abstract(1575) PDF (233KB)(112)
Abstract:

Objective To investigate the value of abnormal prothrombin [protein induced by vitamin K absence or antagonist-Ⅱ( PIVKA-Ⅱ) ]in monitoring the short-term efficacy of transcatheter arterial chemoembolization( TACE) in patients with hepatocellular carcinoma( HCC). Methods A retrospective analysis was p...

Value of indocyanine green retention rate at 15 minutes in predicting the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in liver cancer patients with portal hypertension
Wang Zhong, Yue ZhenDong, Zhao HongWei, Wang Lei, Fan ZhenHua, Wu YiFan, Dong ChengBin, Zhang Yu, Liu FuQuan
2020, 36(9): 1994-1997. DOI: 10.3969/j.issn.1001-5256.2020.09.017
Abstract(1665) PDF (335KB)(118)
Abstract:

Objective To investigate the clinical value of indocyanine green retention rate at 15 minutes( ICG-R15),Child-Turcotte-Pugh( CTP) class,and Model for End-Stage Liver Disease( MELD) score in predicting post-transjugular intrahepatic portosystemic shunt( TIPS) hepatic encephalopathy( HE) in liver canc...

Mechanism of action of Sini powder in treatment of liver cancer based on network pharmacology and molecular docking
Li Jing, Mo JiaHao, Xu HongBin, Zhu JunXia, Shi PeiYu, Xing WanLi, Zhong Chong, Lin LiZhu
2020, 36(9): 1998-2004. DOI: 10.3969/j.issn.1001-5256.2020.09.018
Abstract:
Objective To investigate the mechanism of action of Sini powder in the treatment of liver cancer based on network pharmacology and molecular docking. Methods Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform was used to obtain the compound and target of Sini powder,and...
Original articles_Other liver diseases
Effect of artificial liver support therapy on the short-term prognosis of patients with liver failure in the plateau stage: A stratified analysis based on Model for End-Stage Liver Disease score
Lan XiaoQin, Ji YaLi, Chen JinJun, Zhou FuYuan, Wen WeiQun
2020, 36(9): 2005-2009. DOI: 10.3969/j.issn.1001-5256.2020.09.019
Abstract(1389) PDF (608KB)(123)
Abstract:

Objective To investigate the effect of artificial liver support therapy on the short-term( 28-and 90-day) mortality rate of patients with liver failure in the plateau stage through a stratified analysis based on Model for End-Stage Liver Disease( MELD) score.Methods A retrospective analysis was perf...

Clinical features of Klebsiella pneumoniae liver abscess versus Escherichia coli liver abscess
Yao Na, Kang Wen, Lian JianQi, Wang LinXu, Zhang GuFen, Wang SuNa, Wang ChunFu
2020, 36(9): 2010-2014. DOI: 10.3969/j.issn.1001-5256.2020.09.020
Abstract(1424) PDF (260KB)(144)
Abstract:

Objective To investigate the clinical features of the two most common types of pyogenic liver abscess in clinical practice,Klebsiella pneumoniae liver abscess( KPLA) and Escherichia coli liver abscess( ECLA),and to provide a reference for early diagnosis and effective treatment. Methods A retrospect...

Selection of second-line drugs for adult autoimmune hepatitis: A Meta-analysis
Qian Le, Ying Li
2020, 36(9): 2015-2020. DOI: 10.3969/j.issn.1001-5256.2020.09.021
Abstract:

Objective To investigate the clinical effect and safety of second-line drugs in the treatment of adult patients with autoimmune hepatitis( AIH) through a Meta-analysis of related articles. Methods PubMed,EMBASE,Cochrane Library,Web of Science,CNKI,CBM,Wanfang Data,and VIP were searched for the artic...

An investigation of quality of life and treatment of patients with primary biliary cholangitis
Jia Gui, Shang YuLong, Han Ying
2020, 36(9): 2021-2024. DOI: 10.3969/j.issn.1001-5256.2020.09.022
Abstract(1378) PDF (476KB)(142)
Abstract:

Objective To evaluate the quality of life and treatment of patients with primary biliary cholangitis( PBC) using the PBC-40 scale. Methods The PBC-40 scale was used to perform an investigation of 37 patients who were diagnosed with PBC and received continuous treatment in Department of Gastroenterol...

Serum level of ceruloplasmin in patients with different liver diseases in Jilin,China
Wang ShaSha, Hua Fang, Jiao YongGeng, Qin ErYun, Zhi YiXiao, Pang MengYuan, Xu HongQin, Chi XiuMei, Niu JunQi, Hua Rui
2020, 36(9): 2025-2029. DOI: 10.3969/j.issn.1001-5256.2020.09.023
Abstract(1457) PDF (430KB)(110)
Abstract:
Objective To investigate the serum level of ceruloplasmin in patients with different stages and etiologies of liver diseases.Methods A total of 1077 patients with liver diseases who were hospitalized in Department of Hepatology,The First Hospital of Jilin University,from January 2012 to January 2018...
Effect of anti-liver fibrosis Chinese patent drugs in preventing renal hypofunction associated with alcoholic liver disease
Meng PeiPei, Liu Yao, Zhou MeiYue, Yu Hao, Yang YuYing, Jiang YuYong
2020, 36(9): 2030-2034. DOI: 10.3969/j.issn.1001-5256.2020.09.024
Abstract(1434) PDF (365KB)(117)
Abstract:
Objective To investigate the effect of anti-liver fibrosis Chinese patent drugs on renal hypofunction associated with alcoholic liver disease( ALD). Methods A retrospective analysis was performed for 592 patients with ALD who were admitted to Beijing Ditan Hospital,Capital Medical University,from Au...
Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha rs8192678 single nucleotide polymorphism with the risk of nonalcoholic fatty liver disease
Zhang Qing, Liu ShouSheng, Sun BaoKai, Zhang Mei, Xin YongNing
2020, 36(9): 2035-2039. DOI: 10.3969/j.issn.1001-5256.2020.09.025
Abstract(1317) PDF (263KB)(111)
Abstract:

Objective To investigate the association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha( PPARGC1 A) rs8192678 single nucleotide polymorphism( SNP) with the risk of nonalcoholic fatty liver disease( NAFLD) and the influence of PPARGC1 A rs8192678 SNP on NAFLD-related biochemi...

Effect of cyclooxygenase-2 inhibitors on the expression of the Acsl gene family in the ileum of rats with nonalcoholic fatty liver disease
Guo Shan, Yi ShiJie, Yang XueFeng, Cao Ting, Fu Nian, Zhou KeBing, Long JianWu
2020, 36(9): 2040-2044. DOI: 10.3969/j.issn.1001-5256.2020.09.026
Abstract:

Objective To investigate the effect and significance of cyclooxygenase-2( COX-2) inhibitors on the expression of the Acsl gene family in the ileum of rats with nonalcoholic fatty liver disease( NAFLD). Methods A total of 45 Sprague-Dawley rats were randomly divided into normal control group( 15 rats...

Original articles_Biliary diseases
Measurement and bioinformatics analysis of exosomes microRNAs in bile of hepatic alveolar echinococcosis patients with biliary tract invasion
Wang ZhiXin, Gou Ping, Yu WenHao, Ren Li, Yang DanCaiRang, Wang HaiJiu, Fan HaiNing
2020, 36(9): 2045-2049. DOI: 10.3969/j.issn.1001-5256.2020.09.027
Abstract:

Objective To investigate the expression of exosome microRNAs( miRNAs) in bile of hepatic alveolar echinococcosis( HAE)patients with biliary tract invasion and the regulatory mechanism of differentially expressed miRNAs on target genes. Methods Bile samples were collected from 12 HAE patients who att...

Original articles_Pancreatic diseases
Clinical features of biliary acute pancreatitis versus hypertriglyceridemic acute pancreatitis
Jiang Xin, Yan YongFeng, Zhong Rui, Xu Huan, Peng Yan, Tang XiaoWei
2020, 36(9): 2050-2055. DOI: 10.3969/j.issn.1001-5256.2020.09.028
Abstract(1419) PDF (286KB)(134)
Abstract:

Objective To investigate the clinical features of biliary acute pancreatitis( BAP) and hypertriglyceridemic acute pancreatitis( HTGAP). Methods A total of 378 patients with acute pancreatitis who were admitted to The Affiliated Hospital of Southwest Medical University from September 2018 to August 2...

Brief reports
Diagnostic value of conventional ultrasound and contrast-enhanced ultrasound for focal nodular hyperplasia of the liver
Liu ZhiLong, Zhang Chao, Yan JiPing, Chen Juan, Xu ZiYi
2020, 36(9): 2056-2058. DOI: 10.3969/j.issn.1001-5256.2020.09.029
Abstract:
Hepatectomy as the preferred approach for radical resection of Bismuth Ⅳ hilar cholangiocarcinoma
Wang XueWen, Li Han, Wu YanBin, Niu HongKai, Kong LingQun, Cheng Yu
2020, 36(9): 2059-2062. DOI: 10.3969/j.issn.1001-5256.2020.09.030
Abstract(1233) PDF (873KB)(101)
Abstract:
Case reports
A case of adult cirrhosis with abnormal development of secondary sexual characteristics
Hu ChenBo
2020, 36(9): 2063-2064. DOI: 10.3969/j.issn.1001-5256.2020.09.031
Abstract:
A case of hepatic pheochromocytoma
Wang XiaoLei, Meng ShanShan, Qu LiMei, Wang GuangYi, Wei Feng
2020, 36(9): 2065-2066. DOI: 10.3969/j.issn.1001-5256.2020.09.032
Abstract:
Eszopiclone aggravates liver injury caused by trazodone hepatotoxicity: A case report
Wu Tong, Ma RenShu, Xin GuiJie, Gao RunPing, Yu Ge
2020, 36(9): 2067-2068. DOI: 10.3969/j.issn.1001-5256.2020.09.033
Abstract(1990) PDF (156KB)(118)
Abstract:
A case of recurrent liver dysfunction caused by NBAS gene mutation
Lin Jian, Fang XueQing, Song YouLiang
2020, 36(9): 2069-2071. DOI: 10.3969/j.issn.1001-5256.2020.09.034
Abstract:
Preduodenal portal vein in hepatolithiasis: A case report and literature review
Zhou YangChun, Chu ChaoShun
2020, 36(9): 2072-2074. DOI: 10.3969/j.issn.1001-5256.2020.09.035
Abstract:
Perioperative coagulation factor Ⅷ replacement therapy for patients with gallbladder stones and hemophilia A: A report of three cases
Li ChangXu, Yuan JingJing, Wang ShouQian, Xu LuYao, Wang YingChao
2020, 36(9): 2075-2076. DOI: 10.3969/j.issn.1001-5256.2020.09.036
Abstract:
Pancreas divisum misdiagnosed as intraductal papillary mucinous neoplasms of the pancreas: A case report
He JiaJun, Wang TingTing, Zhou Meng, Wang WeiZhao, Yang ChuTing, Li YuanHao, Chen WeiWei, Liu Jun
2020, 36(9): 2077-2078. DOI: 10.3969/j.issn.1001-5256.2020.09.037
Abstract:
Reviews
Role of hepatic lymphangiogenesis in the progression of liver fibrosis
Shi Na, Chen XiuLi, Wu Hao, Mao JingWei
2020, 36(9): 2079-2082. DOI: 10.3969/j.issn.1001-5256.2020.09.038
Abstract:

Liver fibrosis can progress to liver cirrhosis and end-stage liver disease,which may lead to poor prognosis. In addition to pathological angiogenesis and hepatic sinusoid remodeling,hepatic lymphangiogenesis also plays an important role in the progression of liver fibrosis. This article briefly desc...

Biological characteristics of exosome microRNA and its role in the development and progression of liver fibrosis
Zhang ShiWan, Yu XueQin, Chen Fang, Mei YiHan, Mei XiaoPing
2020, 36(9): 2083-2086. DOI: 10.3969/j.issn.1001-5256.2020.09.039
Abstract:

Exosomes,as a type of multivesicular bodies secreted by various cells in human body,exist in many kinds of body fluids in the body. Exosomes have the structure of lipid bilayer membranes to protect the structure and function stability of their contents and they carry a large number of active substan...

Selection of treatment regimens for early-stage hepatocellular carcinoma
Ren DanDan, Liu Na, Zhou LuLu, Zhang Nan, Li ChunXia, Dong Bing, Xu GuangHua
2020, 36(9): 2087-2091. DOI: 10.3969/j.issn.1001-5256.2020.09.040
Abstract:

Hepatocellular carcinoma( HCC) is one of the most common malignant tumors in the world. At present,the treatment methods for HCC mainly include surgical treatment,local regional treatment,radiotherapy,systematic treatment,and traditional Chinese medicine treatment. This article introduces the indica...

Application value of new liver function scoring models in radiofrequency ablation for hepatocellular carcinoma
Chen MinQiang, Li WenTao, Liu XiaoGuang, Xu Hao, Chen NianPing
2020, 36(9): 2092-2096. DOI: 10.3969/j.issn.1001-5256.2020.09.041
Abstract:

Comprehensive scoring models are one of the main methods for liver function evaluation and an important part of the treatment strategy for hepatocellular carcinoma. This article summarizes the value and limitations of traditional scoring models( Child-Turcotte-Pugh score and Model for End-Stage Live...

Role of statins as a “double-edged sword” in treatment of liver cancer and related mechanisms
Wang FangHua, Zhao ZhiBo, Gong JianPing
2020, 36(9): 2097-2099. DOI: 10.3969/j.issn.1001-5256.2020.09.042
Abstract:

In the past decade,the role of the mevalonic acid pathway and its inhibitor statins in preventing tumorigenesis and improving tumor prognosis has attracted wide attention; however,so far,there are still controversies over the role of statins in liver cancer. Previous studies have shown that statins ...

Regulatory effect of tumor-associated neutrophils in the development and progression of liver cancer
Hu Lei, Gao Li, , Chen AiDong
2020, 36(9): 2100-2102. DOI: 10.3969/j.issn.1001-5256.2020.09.043
Abstract:

The incidence rate of liver cancer keeps increasing in recent years,and this disease has difficulties in early diagnosis,poor treatment outcome,and poor prognosis. This article describes the research advances in tumor-associated neutrophils involved in the regulation of liver tumor microenvironment ...

Current status and prospect of prophylactic lymph node dissection for intrahepatic cholangiocarcinoma
Zhang HeYue, Ju MingGuang, Xu Feng
2020, 36(9): 2103-2106. DOI: 10.3969/j.issn.1001-5256.2020.09.044
Abstract:

Intrahepatic cholangiocarcinoma is a highly invasive malignant tumor,and at present,surgical resection is the only effective way for cure. Lymph node metastasis makes it difficult to accurately judge the extent of radical resection,and no international consensus has been reached on the need for rout...

Research advances of portal vein thrombosis in nonalcoholic fatty liver disease
Gong Hang, Li LiangPing
2020, 36(9): 2107-2110. DOI: 10.3969/j.issn.1001-5256.2020.09.045
Abstract:
Nonalcoholic fatty liver disease( NAFLD) is the most important chronic liver disease in China,with increasing morbidity and mortality rates of extrahepatic diseases such as cardiovascular diseases and portal vein thrombosis( PVT). NAFLD complicated by PVT has a different mechanism from liver cirrhos...
Advances in liraglutide in the treatment of type 2 diabetes with nonalcoholic fatty liver disease
Xie HaiPing, Lin Fan, Chen Yan, Zheng Ming
2020, 36(9): 2111-2114. DOI: 10.3969/j.issn.1001-5256.2020.09.046
Abstract:

Nonalcoholic fatty liver disease( NAFLD) is a common chronic liver disease,and its prevalence rate is increasing year by year.Insulin resistance and oxidative stress are the main pathogeneses of NAFLD,and there are still no effective drugs for the treatment of this disease. Insulin resistance is als...

Advances in the application of non-bioartificial liver in treatment of non-liver failure diseases
Liu Lei, Han Tao
2020, 36(9): 2115-2118. DOI: 10.3969/j.issn.1001-5256.2020.09.047
Abstract:

Non-bioartificial liver is one of the important means for the treatment of liver failure and has been increasingly recognized in recent years,and meanwhile,it has also been widely used in non-liver failure diseases. This article reviews the application of non-bioartificial liver in the treatment of ...

Risk factors for posthepatectomy liver failure and related prevention and treatment methods
Wang CaiBin, Su Yang
2020, 36(9): 2119-2124. DOI: 10.3969/j.issn.1001-5256.2020.09.048
Abstract(1799) PDF (302KB)(152)
Abstract:

Hepatectomy is a common surgical procedure for hepatic surgeries,and due to its high complexity,the mortality rate after hepatectomy is as high as 30%. As one of the most common postoperative complications,posthepatectomy liver failure( PHLF) directly affects the disease-free survival and overall su...

Research advances in high-risk factors for primary biliary cholangitis
Liao HaiLing, Yang JinHui
2020, 36(9): 2125-2128. DOI: 10.3969/j.issn.1001-5256.2020.09.049
Abstract:

Primary biliary cholangitis( PBC) is a multifactorial disease caused by the combined effect of genetic susceptibility and environmental triggers. Among the known risk factors for PBC,environmental factors mainly cause the onset of the disease by disrupting mitochondrial immune tolerance. With the de...

Health-related quality-of-life scales and related influencing factors in patients with primary biliary cholangitis
Yang Xian, Tang YingMei
2020, 36(9): 2129-2132. DOI: 10.3969/j.issn.1001-5256.2020.09.050
Abstract:

Primary biliary cholangitis( PBC) is an autoimmune-mediated chronic progressive liver disease and can progress to liver cirrhosis and liver cancer in the late stage. Clinical manifestations and complications of PBC have significant impact on patients' mind and body,leading to the reduction in Health...

Research advances in Akkermansia muciniphila and liver injury
Liu LiMin, Yao MingJie, Hu DuanMin
2020, 36(9): 2133-2136. DOI: 10.3969/j.issn.1001-5256.2020.09.051
Abstract(1233) PDF (231KB)(108)
Abstract:

Liver injury caused by viral and non-viral factors is an important stage of chronic liver disease,and the pathogenesis of liver injury is still a research hotspot. With the deepening of the research on gut microbiota,substantial evidence indicates that gut microbiota participates in the development ...

Role of prostaglandin E synthases in liver diseases
Cai Jie, Lu JiHong, Gao Hang, Wan ZhiKang, Sun Ying
2020, 36(9): 2137-2140. DOI: 10.3969/j.issn.1001-5256.2020.09.052
Abstract(1079) PDF (229KB)(125)
Abstract:

Prostaglandin E2( PGE2) is a bioactive polyunsaturated fatty acid produced by arachidonic acid,and it is mainly metabolized in the liver and has an important regulatory effect on various liver diseases. Prostaglandin E synthases( PGESs) are important terminal rate-limiting enzymes in the PGE2 synthe...

Research advances in endoscopic lithotripsy for large common bile duct stones
Zhang Qi, Dong Ran, Li Jun
2020, 36(9): 2141-2144. DOI: 10.3969/j.issn.1001-5256.2020.09.053
Abstract:

Endoscopic retrograde cholangiopancreatography( ERCP) and its derivative technologies have become the first-line treatment methods for bile duct stones. Most stones can be removed by conventional endoscopic techniques,while the treatment of large common bile duct stones requires a combination with e...

Application of abnormal cell-free DNA methylation in pancreatic juice in the early diagnosis of pancreatic cancer
Zhou Yan, Ning Bo
2020, 36(9): 2145-2148. DOI: 10.3969/j.issn.1001-5256.2020.09.054
Abstract:

Pancreatic cancer is a digestive system tumor with insidious onset,high malignancy,and difficult diagnosis,and early diagnosis is the key to improving the survival rate and prognosis of patients with pancreatic cancer. This article introduces the research advances in abnormal methylation of cell-fre...

Role of exosomes in the metastasis of pancreatic cancer
Li Rui, Zhang HaiRong, Zhang JingLi, Zhang YuYan, Li RuoChang
2020, 36(9): 2149-2152. DOI: 10.3969/j.issn.1001-5256.2020.09.055
Abstract(1162) PDF (228KB)(100)
Abstract:

Although great achievements have been made in the diagnosis and treatment of pancreatic cancer in the past several decades,the5-year survival rate of this disease is still below 10% due to high degree of malignancy,rapid progression,and strong invasion and metastasis. Exosomes are a class of nanosca...